Literature DB >> 21880771

Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.

Julia M Shaw1, Peter W Hunt, J William Critchfield, Delandy H McConnell, Juan Carlos Garcia, Richard B Pollard, Ma Somsouk, Steven G Deeks, Barbara L Shacklett.   

Abstract

Gut-associated lymphoid tissue (GALT) is a major site of HIV replication and CD4(+) T cell depletion. Furthermore, microbial translocation facilitated by mucosal damage likely contributes to the generalized immune activation observed in HIV infection. Regulatory T cells (Treg) help maintain homeostasis and suppress harmful immune activation during infection; however, in the case of persistent viral infections such as HIV, their role is less clear. Although a number of studies have examined Treg in blood during chronic infection, few have explored Treg in the gastrointestinal mucosa. For this study, paired blood and rectal biopsy samples were obtained from 12 HIV noncontrollers (viral load of >10,000 copies/ml plasma), 10 HIV controllers (viral load of <500 copies/ml plasma for more than 5 years), and 12 HIV seronegative control subjects. Noncontrollers had significantly higher percentages of Treg in rectal mononuclear cells (RMNC), but not in blood, compared to seronegative subjects (P = 0.001) or HIV controllers (P = 0.002). Mucosal Treg positively correlated with viral load (P = 0.01) and expression of immune activation markers by CD4(+) (P = 0.01) and CD8(+) (P = 0.07) T cells. Suppression assays indicated that mucosal and peripheral Treg of noncontrollers and controllers maintained their capacity to suppress non-Treg proliferation to a similar extent as Treg from seronegative subjects. Together, these findings reveal that rather than experiencing depletion, mucosal Treg frequency is enhanced during chronic HIV infection and is positively correlated with viral load and immune activation. Moreover, mucosal Treg maintain their suppressive ability during chronic HIV infection, potentially contributing to diminished HIV-specific T cell responses and viral persistence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880771      PMCID: PMC3194952          DOI: 10.1128/JVI.05608-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  101 in total

Review 1.  Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response?

Authors:  Barbara Fazekas de St Groth; Alan L Landay
Journal:  AIDS       Date:  2008-03-30       Impact factor: 4.177

Review 2.  Natural regulatory T cells and persistent viral infection.

Authors:  Shuo Li; Eric J Gowans; Claire Chougnet; Magdalena Plebanski; Ulf Dittmer
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

3.  Cell interactions in the induction of tolerance: the role of thymic lymphocytes.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1970-05       Impact factor: 7.397

4.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 5.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

6.  Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation.

Authors:  Amanda J Chase; Hung-Chih Yang; Hao Zhang; Joel N Blankson; Robert F Siliciano
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

7.  Mucosal immunity to HIV: a review of recent literature.

Authors:  Barbara L Shacklett
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

8.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

9.  CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.

Authors:  Audrey L Kinter; Margaret Hennessey; Alicia Bell; Sarah Kern; Yin Lin; Marybeth Daucher; Maria Planta; Mary McGlaughlin; Robert Jackson; Steven F Ziegler; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more
  60 in total

1.  Regulatory T cell frequencies do not correlate with breadth or magnitude of HIV-1-specific T cell responses.

Authors:  Mathieu Angin; Hendrik Streeck; Fang Wen; Melanie King; Florencia Pereyra; Marcus Altfeld; Bruce D Walker; Marylyn M Addo
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-05       Impact factor: 2.205

Review 2.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

3.  Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS.

Authors:  Sandra M Gonzalez; Natalia A Taborda; Luis A Correa; Gustavo A Castro; Juan C Hernandez; Carlos J Montoya; Maria T Rugeles
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

4.  Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals.

Authors:  Laura Pattacini; Pamela M Murnane; Erin M Kahle; Michael J Bolton; Jeffrey J Delrow; Jairam R Lingappa; Elly Katabira; Deborah Donnell; M Juliana McElrath; Jared M Baeten; Jennifer M Lund
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-30       Impact factor: 2.205

5.  Neonatal regulatory T cells have reduced capacity to suppress dendritic cell function.

Authors:  Cesar M Rueda; Maria E Moreno-Fernandez; Courtney M Jackson; Suhas G Kallapur; Alan H Jobe; Claire A Chougnet
Journal:  Eur J Immunol       Date:  2015-06-25       Impact factor: 5.532

6.  Preserved function of regulatory T cells in chronic HIV-1 infection despite decreased numbers in blood and tissue.

Authors:  Mathieu Angin; Douglas S Kwon; Hendrik Streeck; Fang Wen; Melanie King; Ashley Rezai; Kenneth Law; Tomoyuki C Hongo; Augustine Pyo; Alicja Piechocka-Trocha; Ildiko Toth; Florencia Pereyra; Musie Ghebremichael; Scott J Rodig; Danny A Milner; James M Richter; Marcus Altfeld; Daniel E Kaufmann; Bruce D Walker; Marylyn M Addo
Journal:  J Infect Dis       Date:  2012-03-15       Impact factor: 5.226

Review 7.  Homeostasis and function of regulatory T cells in HIV/SIV infection.

Authors:  Maria E Moreno-Fernandez; Pietro Presicce; Claire A Chougnet
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

Review 8.  Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.

Authors:  LiGuo Zhang; Eric Meissner; JianZhu Chen; LiShan Su
Journal:  Sci China Life Sci       Date:  2010-03-07       Impact factor: 6.038

9.  Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

Authors:  J Saison; T Ferry; J Demaret; D Maucort Boulch; F Venet; T Perpoint; F Ader; V Icard; C Chidiac; G Monneret
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 10.  The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon Infection.

Authors:  Laura E Richert-Spuhler; Jennifer M Lund
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-18       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.